Pharma Focus Europe-Newsletter
Pharma Focus Europe
Pharma Focus Europe is a Bi-Annual publication from Ochre Media Pvt. Ltd.
Latest Articles
High accessibility to medicines is still a concern in Europe due to increasing costs and variability in price per country and a lack of legislation to mitigate the problem. The problem of high prices impacts a healthcare system and limits patients’ access to treatment. They are generic medicines promoted, starker pricing talks, and increased regional collaboration for permanent, non-discriminatory access to key medicines for each and every European.
In this article, we discuss new approaches to drug pricing in the EU: value-based pricing, risk sharing, subscription and differential pricing. These strategies are to achieve cost reduction for medicines now and in the future to be more affordable, sustained and accessible, and to advance pharmaceutical innovation. Future trends, opportunities and threats such as regulation and structuring of data are also examined.
The compliance of the European pharmaceutical industry comes with complex works in 2025 as pharmacovigilance, sustainability requirements, clinical trial regulations, data protection regulation, and supply chain regulation. This article focuses on these challenges and provides practical future steps using available technologies and teamwork to overcome them while keeping up with current state and federal laws.
To the extent that it is recognized as a vital source of information, the pharmaceutical industry relies heavily on credible blogs and publications. These platforms not only provide insights into the latest research and trends, but also foster discussions that can influence policy and practice within the healthcare sector.
Expert Interviews
Author: Arul Joseph PhD MBA, Senior Director of Pharmaceutical Development at Otsuka Pharmaceutical Companies (U.S.)
We asked Arul Joseph to share his thoughts on how to effectively manage the pharmaceutical development and manufacturing of drug substances and drug products to meet clinical supply needs from the early to late stages of development in the pharmaceutical industry.
Author: Kishore Hotha, PhD, MBA, President, Dr.Hotha's Life Sciences LLC
Biotech, CDMOs, and big pharma must collaborate strategically to balance innovation with risk management in R&D. By combining biotech’s agility, CDMOs' specialized expertise, and big pharma’s robust risk frameworks, they can efficiently and safely navigate drug development, ensuring groundbreaking therapies advance from discovery to commercialization.
Author: Preetha Vasanji, President-Emerging Markets, Doceree
Can you provide an overview of your journey in the healthcare communications and marketing sector?
My journey in healthcare communications and marketing began at McCann Health in Mumbai about two decades ago, where I eventually became the general manager, leading a team of over 30 professionals. I met many extraordinary minds there, one of which was Harshit Jain, MD. I joined him in his venture, Doceree, in 2020.
Industrial Events
领英推荐
Industrial Projects
Merck Company has announced €70 million to expand its ADC manufacturing capabilities in the USA. This expansion will significantly increase capacity, tripling the current levels, and strengthen the company’s contract development and manufacturing organization (CDMO) services, reaffirming its dedication to supporting clients and patients.
Piramal Pharma Solutions (PPS) is investing $80M to expand its Lexington, Kentucky facility. This site specializes in sterile injectable drug products, including compounding, liquid filling, and lyophilization. The expansion will support PPS's ADCelerate? program for antibody-drug conjugates and enhance capacity to meet growing market demand.
AstraZeneca has unveiled plans for a $3.5 billion capital investment in the United States to enhance its research and manufacturing capabilities. This initiative includes $2 billion allocated to new projects, which are set to generate over a thousand high-skilled jobs, bolstering the U.S. economy.
Most Engaging Articles
Author: Juan José L., Associate Director of Cyber Security Architecture and Governance, Life Sciences Manufacturing, Cognizant
In this article, Juan Jose Lopez, Associate Director of Cyber Security Architecture and Governance, Life Sciences Manufacturing at Cognizant, will explore the challenges of AI and how companies can overcome them to effectively harness AI to keep safe their most valuable asset—their data.
Author: Vikalp Khare, Director, Otsuka Pharmaceutical Companies (U.S.)
This article explores the details of a typical pharmacovigilance (PV) information technology ecosystem setup & maintenance, which is essential for any pharmaceutical company to ensure the safety of the patients consuming their medicinal products. The article also touches upon a possible controlled approach of leveraging AI & ML to establish an efficient, effective & cost-benefiting PV-IT ecosystem.
Author: Marek Skowronek, Quality Systems Manager, StatSoft Polska
The article presents recent EMA recommendations and proposed methods for comparing dissolution profiles, particularly when the prerequisites for the standard f2 similarity factor method are not met. A method selection scheme is discussed, supported by case studies that highlight the advantages and disadvantages of various dissolution profile methods, along with practical insights.
Press Releases
?????? ???????????? ???????????????? ?????????? ???????????????? ?????????????????? ??????????????, ???????????? ????????????????, ???????????????? ?????????????? ?????? ???????????? ?????????????? ???? ?????? ???????????????????????????? ???????????? ??????'?? ???????? ????! https://www.pharmafocuseurope.com/magazine
?????????? ?????? ??????????????: https://www.pharmafocuseurope.com
?????????????????? ???????? ???? ?????????????? ?????? ???????? ???????????? ??????????????: https://www.pharmafocuseurope.com/subscribe
?????????????? ?????? ???????????????? ????????????: https://www.pharmafocuseurope.com/archives
???????????????????? ???? ?????????????????????? ???????? ???????????? ?????????? ????????????? ???????????????? ?????? ?????????? ???????? ????????: https://www.pharmafocuseurope.com/advertise